Chan Zuckerberg Biohub Expands $1.8 Billion Virtual Biology Initiative with Major Tech Partners

The Chan Zuckerberg Biohub has announced an expansion of its Virtual Biology Initiative, increasing its total investment to $1.8 billion. This initiative aims to create AI models that simulate the behavior of living cells in response to various perturbations, such as drugs or genetic changes.

On October 7, 2026, the Biohub revealed that it has secured additional funding from significant players in the tech industry, including Google DeepMind, Meta Platforms, and Isomorphic Labs, which collectively contributed $300 million. The US Department of Energy is also set to invest over $500 million over the next five years to support advanced measurement and modeling efforts.

The initiative, which originally launched in April 2026 with a $500 million commitment, aims to address the limitations of existing biological datasets, which contain only hundreds of millions of cellular data points. The goal is to generate open datasets that can help researchers understand how cells respond to various changes, thereby speeding up drug development timelines from decades to approximately five years.

Key milestones for the initiative include the expected release of the first dataset in about a year and the development of accurate virtual cell models within five years. The Biohub emphasizes an open science approach, ensuring that all data and models produced will be accessible to researchers worldwide.